Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts.
Weber
Karl T
KT
D000626:Aminopeptidases / Q000008:administration & dosage* / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D000818:Animals; D003094:Collagen / Q000187:drug effects* / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology; D005355:Fibrosis; D006331:Heart Diseases / Q000473:pathology*; D006801:Humans; D006973:Hypertension / Q000473:pathology*; D007930:Leucine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017706:Lisinopril / Q000008:administration & dosage; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism / Q000473:pathology*; D007703:Peptidyl-Dipeptidase A / Q000187:drug effects / Q000378:metabolism; D011480:Protease Inhibitors / Q000008:administration & dosage
D000806:Angiotensin-Converting Enzyme Inhibitors; D011480:Protease Inhibitors; D003094:Collagen; D017706:Lisinopril; D000626:Aminopeptidases; D007703:Peptidyl-Dipeptidase A; D007930:Leucine; C012211:ubenimex